IL is only effective with specific Kidney Cancers. This is a direct quote and the link is at the end:
IL-2 has a CR 7% unless the presence of alveolar features, no papillary features, granular features < 50% and major renal vein involvement. Pts with all these features had a 41% RR (16/39). Source: 2003 ASCO Annual Meeting
As far as the trial goes, that's why you have an early scan, normaly a...
June 04, 2012